π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The overall aim of this cluster ranomized controlled trial is to investigat...
Status
Unknown
Location
Region Uppsala
Start Date
2022-02-15
Trial ID
NCT05216861
Treatments Being Tested
Hypothesis: 3,4-Diaminopyridine base (3,4-DAP) improves Lambert-Eaton Myast...
Status
Completed
Location
University of California at Davis
Start Date
2012-01
Trial ID
NCT01511978
Treatments Being Tested
This randomized, double-blind, controlled, outpatient two-period, two-treat...
Status
Completed
Location
UCLA Department of Neurology
Start Date
2016-01
Trial ID
NCT02562066
Treatments Being Tested
The aim of this randomized trial is to assess the efficacy of analgesia usi...
Status
Completed
Location
Medical University of Silesia
Start Date
2017-12-12
Trial ID
NCT06609993
Treatments Being Tested
Primary: The primary objective of this study under the original protocol w...
Status
Approved For Marketing
Location
UCLA
Start Date
TBD
Trial ID
NCT02189720
Treatments Being Tested
A new drug called 3,4-Diaminopyridine (3,4-DAP) is currently under investig...
Status
No Longer Available
Location
University of California, Davis
Start Date
TBD
Trial ID
NCT00704925
Treatments Being Tested
The main purpose for this study is to provide access to 3,4 DAP, a drug whi...
Status
Terminated
Location
Dartmouth-Hitchcock Medical Center
Start Date
2004-02
Trial ID
NCT02090725
Treatments Being Tested
A two-period, two-treatment, crossover study to evaluate the safety, tolera...
Status
Completed
Location
Neurological Institute Carlo Besta
Start Date
2019-01-21
Trial ID
NCT03781479
Treatments Being Tested
if amifampridine can improve neuromuscular transmission in muscles previous...
Status
Completed
Location
Wake Forest University Health Sciences
Start Date
2023-09-15
Trial ID
NCT05769478
Treatments Being Tested
A long term safety study of amifampridine phosphate in patients with spinal...
Status
Terminated
Location
Neurological Institute Carlo Besta
Start Date
2019-03-07
Trial ID
NCT03819660
Treatments Being Tested